Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood Pressure

Amanda J. Rickard, James J. Morgan, Greg H. Tesch, John W. Funder, Peter J. Fuller, Morag J. Young

Hypertension · 2009 · 296 citations · 41 references

DOIFull text

Open access

Concepts

TL;DR

Mineralocorticoid excess combined with high salt drives vascular inflammation and cardiac remodeling, yet the contribution of macrophage mineralocorticoid receptors remains unexplored. The authors generated LysM‑Cre‑mediated MR knockout mice, uninephrectomized them, and administered deoxycorticosterone or vehicle for 8 days or 8 weeks to assess macrophage‑specific effects. Loss of MR in macrophages abolished deoxycorticosterone‑induced increases in PAI‑1, NADPH oxidase, and cardiac fibrosis and prevented the rise in systolic blood pressure, demonstrating a pivotal role for macrophage MR signaling in cardiac remodeling and hypertension.

Abstract

Increased mineralocorticoid levels plus high salt promote vascular inflammation and cardiac tissue remodeling. Mineralocorticoid receptors are expressed in many cell types of the cardiovascular system, including monocytes/macrophages and other inflammatory cell types. Although mineralocorticoid receptors are expressed in monocytes/macrophages, their role in regulating macrophage function to date has not been investigated. We, thus, used the Cre/LoxP-recombination system to selectively delete mineralocorticoid receptors from monocytes/macrophages with the lysozyme M promoter used to drive Cre expression (MR flox/flox /LysM Cre/− mice). Male mice from each genotype (MR flox/flox or wild-type and MR flox/flox /LysM Cre/− mice) were uninephrectomized, given 0.9% NaCl solution to drink, and treated for 8 days or 8 weeks with either vehicle (n=10) or deoxycorticosterone (n=10). Equivalent tissue macrophage numbers were seen for deoxycorticosterone treatment of each genotype at 8 days; in contrast, plasminogen activator inhibitor type 1 and NAD(P)H oxidase subunit 2 levels were increased in wild-type but not in MR flox/flox /LysM Cre/− mice given deoxycorticosterone. Baseline expression of other inflammatory genes was reduced in MR flox/flox /LysM Cre/− mice compared with wild-type mice. At 8 weeks, deoxycorticosterone-induced macrophage recruitment and connective tissue growth factor and plasminogen activator inhibitor type 1 mRNA levels were similar for each genotype; in contrast, MR flox/flox /LysM Cre/− mice showed no increase in cardiac fibrosis or blood pressure, as was seen in wild-type mice at 8 weeks. These data demonstrate the following points: (1) mineralocorticoid receptor signaling regulates basal monocyte/macrophage function; (2) macrophage recruitment is not altered by loss of mineralocorticoid receptor signaling in these cells; and (3) a novel and significant role is seen for macrophage signaling in the regulation of cardiac remodeling and systolic blood pressure in the deoxycorticosterone/salt model.

References

41